- Uli Hacksell assumed leadership responsibility for Medivir as acting CEO in the fall of 2018 in conjunction with the strengthened focus on clinical cancer projects and a comprehensive restructuring of the company. Uli has invested enormous energy in shaping and developing Medivir into the company it is today.

Uli Hacksell View Synthesis of perhydro-1,4-ethano-1,5-naphthyridine and perhydro-4,7-ethanopyrrolo[3,2-b]pyridine derivatives: potential NK1-receptor antagonists.

Uli has 1 job listed on their profile. See the complete profile on LinkedIn and discover Uli’s connections BALITIMORE, MD -- (Marketwired) -- 08/14/17 -- Cerecor Inc. (NASDAQ: CERC), a clinical-stage biopharmaceutical company developing innovative drug candidates for patients with neurologic and neuropsychiatric disorders, today announced that Dr. Uli Hacksell has retired as Cerecor's President and Chief Executive Officer, effective Monday, August 14, 2017. John Kaiser, Chief Business Officer of Cerecor, has been appointed Interim Chief Executive Officer. SAN DIEGO--(BUSINESS WIRE)--Mar.

Uli hacksell biography

Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $59,600 and over the last 17 years Uli sold CERC stock worth over $0.Cerecor Inc stock worth over $59,600 and over the last 17 years Uli sold CERC stock worth over $0. The estimated Net Worth of Uli Hacksell is at least $65.8 Mille dollars as of 10 December 2016. Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $65,800 and over the last 17 years Uli sold CERC stock worth over $0.Cerecor Inc stock worth over $65,800 and over the last 17 years Uli sold CERC stock worth over $0. Uli Hacksell A number of 3-heteroaryl-substituted quinuclidin-3-ol and quinuclidin-2-ene derivatives have been prepared and evaluated for muscarinic and antimuscarinic properties. About Uli Hacksell, PhD. Dr. Hacksell served as Chief Executive Officer of ACADIA from September 2000 to March 2015 and was a member of its Board of Directors.

Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $61,000 and over the last 17 years Uli sold CERC stock worth over $0.Cerecor Inc stock worth over $61,000 and over the last 17 years Uli sold CERC stock worth over $0. Dr. Uli Hacksell, since May 3, 2018, a board member of Medivir, has held senior positions in major pharmaceutical and biotech companies for over 25 years and has more than 10 years’ experience as the CEO of publicly owned companies. July 9, 2015 – InDex Pharmaceuticals today announced that Uli Hacksell and Jesper Wiklund have been appointed as new members of the Board of Directors.

2 hours ago

Born: 1950 Title: Member of the Board since 2018. Education: PhD at Uppsala University. Background: Senior positions in major pharmaceutical and biotech companies for over 25 years and more than 10 years’ experience as the CEO of publicly owned companies. Uli Hacksell.

She had three daughters: Monica Svensson born 1955 Malin Berghagen born 1966 Anders Karlen Uli Hacksell Kjell Svensson Arvid Carlsson Lennart Kenne

Det framgår av Finansinspektionens insynsregister, där den 16 anges som transaktionsdatum. Uli Alf Hacksell is a businessperson who has been at the helm of 9 different companies is on the board of Active Biotech AB and 5 other companies. In his past career he was Chairman at Glionova AB, Uli är synnerligen kvalificerad att ta över ledarskapet och hans dokumenterade erfarenhet från klinisk utveckling blir en stor tillgång för Medivir, säger styrelseordförande Anna Malm Bernsten, i pressmeddelandet. Uli Hacksell är ett känt ansikte för många farmaceuter. Uli Hacksell har tidigare varit vd för forskningsbolaget Medivir och har under 90-talet innehaft seniora positioner vid Astra, numera Astra Zeneca. Han är för närvarande även styrelsemedlem i bland annat forskningsbolagen Active Biotech, Index Pharmaceuticals och Medivir.

In his past career he was Chairman at Glionova AB, Uli Hacksell View Synthesis of perhydro-1,4-ethano-1,5-naphthyridine and perhydro-4,7-ethanopyrrolo[3,2-b]pyridine derivatives: potential NK1-receptor antagonists. SAN DIEGO--(BUSINESS WIRE)--Mar. 11, 2015-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological and related central nervous system disorders, today announced that Uli Hacksell, Ph.D., has retired as ACADIA’s Chief Executive Officer and as a member of the Board of Directors, effective today. Uli Hacksell ist derzeit Board Member bei Active Biotech, Chairman of the Board bei Adhera Therapeutics und Director (promoted on May 5 2021 to Chairman of the Board) bei Medivir. Uli Hacksell, born 1950, is a trained pharmacist and holds a PhD from Uppsala University.
Magnus lundstedt

Uli Hacksell kan tyckas personifiera den forskarflykt som enligt många drabbat Sverige, men han har inte klippt banden med moderlandet helt och hållet. I sommar lär han exempelvis kunna påträffas i trakterna av Sandhamn i Stockholms skärgård. Login Problem! You have entered an invalid email or you are have not registered.

Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $59,600 and over the last 17 years Uli sold CERC stock worth over $0. Hans Gunnar Hacksell, född 20 augusti 1938 i Stockholm, död 20 mars 2015, var en svensk officer i Armén. [1 Biografi.
Autodesk investor relations

heby kommun
vätskor ryan air
faktura avgift tre
skattesats pensionärer 2021
kvinnliga föreläsare om ledarskap
ikea varuhus

STOCKHOLM (Nyhetsbyrån Direkt) Uli Hacksell, tidigare vd för och numera styrelseledamot i Medivir, har köpt 52.000 aktier i Medivir för 8:78 kronor styck, motsvarande en totalsumma om nära en halv miljon kronor. Det framgår av Finansinspektionens insynsregister, där den 16 anges som transaktionsdatum.

Uli Hacksell.